Fundraising Fox

Epikast

Brooklyn, US · Founded 2022 · Delaware corporation · 2 known investors

Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe. The company combines peer-to-peer engagement models, medical expertise, and proprietary AI insights to reduce costs and improve stakeholder outreach.

Founders & leadership

EV
Evangelos VergetisNamed on SEC filing

Board

ONOleg Nodelman
Oleg NodelmaninBoard directorFounder and Portfolio Manager at EcoR1 Capital
BP
Brad ProsekBoard director
SP
Stelios PapadopoulosBoard director
DK
Daphne KarydasBoard director
AT
Alexandros TzoukasBoard director
DP
Dimitrios PapalexopoulosBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$5.7M disclosed across 2 rounds · 2023–2026

$700KraisedFeb 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad ProsekDirector
  • Evangelos VergetisExecutive Officer, Director
  • Oleg NodelmanDirector
  • Stelios PapadopoulosDirector
  • Daphne KarydasDirector
  • Alexandros TzoukasDirector
  • Dimitrios PapalexopoulosDirector
Offering amount
$2.2M
Amount sold
$700K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedFeb 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Evangelos VergetisExecutive Officer, Director
  • Stelios PapadopoulosDirector
Offering amount
$10M
Amount sold
$5M
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Epikast do?
Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe. The company combines peer-to-peer engagement models, medical expertise, and proprietary AI insights to reduce costs and improve stakeholder outreach.
Who are Epikast's investors?
Epikast's investors include EcoR1 Capital, Vedanta Capital.
How much funding has Epikast raised?
Epikast has disclosed $5.7M raised across 2 rounds.
Where is Epikast headquartered?
Epikast is headquartered in Brooklyn, US.